Peptipedia
BioregulatorNot FDA ApprovedAnimal Studies

Pinealon

Also known as EDR, Glu-Asp-Arg

A synthetic tripeptide bioregulator targeting brain tissue, designed to support cognitive function and neuroprotection as part of Khavinson's peptide research.

Available in Russia - Not FDA approved
CompareFind Vendors

Regulatory Pathway

Preclinical
Phase I
Phase II
Phase III
Phase IV
Approved

Dosing Protocol

Typical Dose

10-20 mg daily

Frequency

Once daily, typically evening

Duration

10-30 day courses

Community-reported dosing. Individual results vary. Not a medical recommendation.
Typical community protocol: 10-20 mg daily via Oral or sublingual, Once daily, typically evening. Dose range: 10-20 mg daily. Duration: 10-30 day courses.

Timing & Administration

Administer via Oral or sublingual. Frequency: Once daily, typically evening.

Mechanism of Action

Regulates gene expression in brain cells involved in neuronal survival. Modulates melatonin synthesis, supports circadian rhythm, and provides antioxidant effects in neural tissue.

Research Summary

Evidence level: animal studies. Clinical status: Available in Russia - Not FDA approved.

Side Effects & Safety

Important Warnings

  • Caution advised with seizure disorders
Headache
nausea
dizziness
vivid dreams
injection site reactions

References

No references available.

Related Peptides

Browse all →
EpithalonBioregulator

A tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties.

View profile
ThymalinBioregulator

A thymic peptide complex utilized in Russia for immune enhancement and longevity support, developed through Professor Khavinson's bioregulator peptide research.

View profile
VilonBioregulator

A synthetic dipeptide bioregulator targeting thymic function. Part of Khavinson's peptide bioregulator research for immune and anti-aging effects.

View profile